TAMs can augment tumor cell migration with epidermal growth factor (EGF), proliferation with platelet-derived growth factor (PDGF), and angiogenesis with vascular endothelial growth factor (VEGF) [96,97,98]. This evidence concerns the gene EGF and neoplasm.